Cargando…

Durable response to mTOR inhibition in a patient with relapsing papillary tumor of the pineal region

Detalles Bibliográficos
Autores principales:	Belting, Mattias, Bång-Rudenstam, Anna, Englund, Elisabet, Pietsch, Torsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303426/ https://www.ncbi.nlm.nih.gov/pubmed/30295836 http://dx.doi.org/10.1093/neuonc/noy153

Ejemplares similares

Pro-metastatic functions of lipoproteins and extracellular vesicles in the acidic tumor microenvironment
por: Bång-Rudenstam, Anna, et al.
Publicado: (2019)

Papillary tumor of the pineal region accompanied by Parinaud’s syndrome: magnetic resonance imaging findings
por: Ribeiro, Bruno Niemeyer de Freitas, et al.
Publicado: (2018)

An Unusual Finding: Papillary Tumor of the Pineal Region
por: Kennedy, Grace, et al.
Publicado: (2023)

Papillary tumor of pineal region: A rare entity
por: Patil, Meena, et al.
Publicado: (2016)

Bevacizumab is Effective for Recurrent Papillary Tumor of the Pineal Region: First Report
por: Cohen, Adam L., et al.
Publicado: (2013)

Papillary Tumor of the Pineal Region: MR Signal Intensity Correlated to Histopathology
por: Rosa Junior, Marcos, et al.
Publicado: (2015)

Papillary tumor of the pineal region: A case report and review of the literature
por: HUA, XIAOMIN, et al.
Publicado: (2015)

Papillary tumor of the pineal region with extended clinical and radiologic follow-up
por: Shakir, Hakeem J., et al.
Publicado: (2015)

Unedited microneurosurgery of a large recurrent papillary tumor of the pineal region
por: Choque-Velasquez, Joham, et al.
Publicado: (2018)

Papillary tumor of the pineal region: Is stereotactic radiosurgery efficient for this rare entity?
por: Bechri, Hajar, et al.
Publicado: (2021)

Papillary tumor of the pineal region in pediatric patient – A case report
por: Nemir, Jakob, et al.
Publicado: (2022)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

Recurrent Papillary Tumor of Pineal Region Misdiagnosed as Pineocytoma 9-Years Ago
por: Mehta, Nirav, et al.
Publicado: (2021)

Clinical Implications of mTOR Expression in Papillary Thyroid Cancer—A Systematic Review
por: Derwich, Aleksandra, et al.
Publicado: (2023)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

mTOR inhibitors: A novel class of anti-cancer agents
por: Riaz, Haris, et al.
Publicado: (2012)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017)

Overcoming mTOR Resistance Mutations with a New Generation mTOR Inhibitor
por: Rodrik-Outmezguine, Vanessa S., et al.
Publicado: (2016)

Papillary tumor of pineal region with an unusual clinical presentation: Case report and review of the literature
por: Aggarwal, Sushil Kumar, et al.
Publicado: (2016)

OTHR-15. Papillary tumor of the pineal region: case series of this rare pediatric entity
por: Shatara, Margaret, et al.
Publicado: (2022)

mTOR and lysosome regulation
por: Puertollano, Rosa
Publicado: (2014)

mTOR, autophagy, and reprogramming
por: Tang, Bor Luen
Publicado: (2014)

Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015)

mTOR in cerebrovascular disease
por: Van Skike, Candice E., et al.
Publicado: (2019)

mTOR and Tumor Cachexia
por: Duval, Adrian P., et al.
Publicado: (2018)

Double agent mTOR
por: Danzer, Steve C.
Publicado: (2019)

mTOR in Human Diseases
por: Dormond, Olivier
Publicado: (2019)

ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer
por: Farmaki, Elena, et al.
Publicado: (2023)

Pineal region tumors
por: Boop, Frederick A., et al.
Publicado: (2021)

Commentary: Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
por: Renna, Maurizio
Publicado: (2016)

Temporal changes in mammalian target of rapamycin (mTOR) and phosphorylated-mTOR expressions in the hippocampal CA1 region of rat with vascular dementia
por: Park, Jin-A, et al.
Publicado: (2017)

Targeting the mTOR Signaling Pathway in Neuroendocrine Tumors
por: Chan, Jennifer, et al.
Publicado: (2014)

miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma
por: Minna, Emanuela, et al.
Publicado: (2016)

Hyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cells
por: Hanly, Elyse K., et al.
Publicado: (2015)

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma
por: Witzig, T E, et al.
Publicado: (2011)

How do mTOR inhibitors fit in the landscape of treatment for relapsed acute lymphoblastic leukemia?
por: Pinchinat, Ashley, et al.
Publicado: (2022)

mTOR and its link to the picture of Dorian Gray - re-activation of mTOR promotes aging
por: Węsierska-Gądek, Józefa
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_fb8hnog4qqe9pbnnm3t279060v